RON MARTELL - 21 Mar 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
President, CEO and Director, Director
Signature
/s/ Ronald A. Martell
Issuer symbol
JSPR
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
4
Filing time
23 Mar 2022, 18:06:16 UTC
Previous filing
21 Mar 2022
Next filing
13 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +1,704,328 $0.000000 1,704,328 21 Mar 2022 Common Stock 1,704,328 $3.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on March 15, 2023, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.